Stansberry Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,462
Closed -$2.23M 110
2023
Q2
$2.23M Sell
13,462
-445
-3% -$71.8K 0.41% 71
2023
Q1
$2.16M Sell
13,907
-7,883
-36% -$1.27M 0.42% 63
2022
Q4
$3.85M Buy
21,790
+757
+4% +$131K 0.79% 40
2022
Q3
$3.44M Buy
21,033
+1,840
+10% +$311K 0.74% 45
2022
Q2
$3.41M Sell
19,193
-954
-5% -$170K 0.73% 48
2022
Q1
$3.57M Buy
20,147
+1,143
+6% +$194K 0.58% 46
2021
Q4
$3.25M Buy
19,004
+2,944
+18% +$482K 0.52% 45
2021
Q3
$2.59M Buy
+16,060
New +$2.74M 0.52% 45

Other funds holding JNJ

Stansberry Asset Management's JNJ Position: Q3 2023 in Review

Stansberry Asset Management sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 13,462 shares — an estimated $2.23M sold.

Stansberry Asset Management first reported a position in JNJ in Q3 2021 and held it in 8 quarters. The position peaked at $3.85M in Q4 2022. 3,679 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • Stansberry Asset Management reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
  • Stansberry Asset Management sold 13,462 Johnson & Johnson shares in Q3 2023, an estimated $2.23M.
  • Stansberry Asset Management first reported a position in Johnson & Johnson in Q3 2021 and held it in 8 quarters.
  • Stansberry Asset Management's Johnson & Johnson position peaked at $3.85M in Q4 2022.
  • 3,679 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Stansberry Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.